While some analysts questioned why Medtronic would leave a fast-growing market, others backed the company’s plan to focus on ...

CEO Geoff Martha told investors the split simplifies Medtronic’s portfolio, while creating a stand-alone diabetes tech ...

Many companies forecast specific tariff charges. Then the White House and China agreed to a 90-day pause in their trade ...

The company will compete with a device Boston Scientific acquired for $850 million.

“For too long, Johnson & Johnson has used tying arrangements and other tactics to interfere with fair competition from ...

EndoQuest Robotics completed two procedures with its endoluminal system, while Virtuoso Surgical successfully performed ...

Roche Diagnostics plans to produce glucose monitors at the site within three years and prepare for future generations of its ...

The White House will alert countries of their specific rates in the next two to three weeks, President Donald Trump said ...

Inside the evolving science of sterilization compatibility and why your next packaging decision might improve patient ...

Teal won FDA approval for a self-collection device after running a study at 16 sites in the U.S. Writing in the JAMA paper, ...

The biotech, which has for years invested in genetics research, plans to acquire "substantially all" of testing firm ...

CEO Bryan Hanson said tariffs have given “a higher sense of urgency” to the company’s existing efforts to regionalize its ...